866-997-4948(US-Canada Toll Free)

IRIS International, Inc. (IRIS) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Apr 2012

Category :

Surgical Equipment

No. of Pages : 33 Pages


IRIS International, Inc. (IRIS) designs, develops, manufactures and markets in-vitro diagnostic imaging products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The company carries out its business through three reportable business segments, namely, In-Vitro Diagnostics (IVD), Sample Processing segment and Prescribed Medicine Segment. In addition, it also offers products in relation with cytology, hematology, and urinalysis for the clinical and veterinary markets.

This report is a source for data, analysis and actionable intelligence on the IRIS International, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3
IRIS International, Inc. - Business Description 4
Key Facts 6
IRIS International, Inc. - Major Products and Services 7
IRIS International, Inc. Pipeline Products by Equipment Type 8
IRIS International, Inc. Pipeline Products by Development Stage 10
IRIS International, Inc. Pipeline Products by Therapy Area 12
3GEMS Hematology Analyzer 14
3GEMS Hematology Analyzer Product Status 14
3GEMS Hematology Analyzer Product Description 14
3GEMS Hematology Analyzer Product Patent Details 14
3GEMS Next Generation Urinalysis Platform 17
3GEMS Next Generation Urinalysis Platform Product Status 17
3GEMS Next Generation Urinalysis Platform Product Description 17
iQ Urine Bacteria Screening Test 18
iQ Urine Bacteria Screening Test Product Status 18
iQ Urine Bacteria Screening Test Product Description 18
NADIA CEC - Breast Cancer 19
NADIA CEC - Breast Cancer Product Status 19
NADIA CEC - Breast Cancer Product Description 19
NADIA CEC - Prostate Cancer 20
NADIA CEC - Prostate Cancer Product Status 20
NADIA CEC - Prostate Cancer Product Description 20
NADiA HIV 21
NADiA HIV Product Status 21
NADiA HIV Product Description 21
IRIS International, Inc. - Key Competitors 22
IRIS International, Inc. - Key Employees 23
IRIS International, Inc. - Key Employee Biographies 24
IRIS International, Inc. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
IRIS International, Inc., Recent Developments 26
Mar 01, 2012: IRIS International Reports Revenue Of $118.3m In 2011 26
Nov 03, 2011: IRIS International Reports Revenues Of $28.1m In Q3 2011 27
Aug 03, 2011: IRIS International Reports Total Revenues Of $30.2m In Q2 2011 28
May 04, 2011: IRIS International Reports Total Revenues Of $26.9m In Q1 2011 29
Apr 06, 2011: IRIS International Begins US Commercial Shipments Of iChemVELOCITY And iRICELL Urinalysis Workstation 30
Mar 03, 2011: IRIS Renews Supply Agreement For Full Line Of Urinalysis Instrumentation, Consumables And Service With U.S. Department Of Veterans Affairs National Acquisition Center 30
Feb 28, 2011: IRIS International Reports Net Income Of $3m In 2010 31
Feb 15, 2011: IRIS Appoints Richard O\'Leary As Corporate Vice President, Human Resources And Administration 32

Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Table

 
IRIS International, Inc., Key Facts 1
IRIS International, Inc. Key Pipeline Products by Equipment Type 1
IRIS International, Inc. Key Pipeline Products by Therapy Area 1
IRIS International, Inc. Key Pipeline Products by Development Stage 1
IRIS International, Inc., Key Facts 6
IRIS International, Inc., Major Products and Services 7
IRIS International, Inc. Number of Pipeline Products by Equipment Type 8
IRIS International, Inc. Pipeline Products by Equipment Type 9
IRIS International, Inc. Number of Pipeline Products by Development Stage 10
IRIS International, Inc. Pipeline Products by Development Stage 11
IRIS International, Inc. Number of Pipeline Products by Therapy Area 12
IRIS International, Inc. Pipeline Products by Therapy Area 13
3GEMS Hematology Analyzer - Product Status 14
3GEMS Hematology Analyzer - Product Description 14
3GEMS Hematology Analyzer - Patent Details 14
3GEMS Next Generation Urinalysis Platform - Product Status 17
3GEMS Next Generation Urinalysis Platform - Product Description 17
iQ Urine Bacteria Screening Test - Product Status 18
iQ Urine Bacteria Screening Test - Product Description 18
NADIA CEC - Breast Cancer - Product Status 19
NADIA CEC - Breast Cancer - Product Description 19
NADIA CEC - Prostate Cancer - Product Status 20
NADIA CEC - Prostate Cancer - Product Description 20
NADiA HIV - Product Status 21
NADiA HIV - Product Description 21
IRIS International, Inc., Key Employees 23
IRIS International, Inc., Key Employee Biographies 24
IRIS International, Inc., Other Locations 25
IRIS International, Inc., Subsidiaries 25

List of Chart


IRIS International, Inc. Key Pipeline Products by Equipment Type 1
IRIS International, Inc. Pipeline Products by Equipment Type 8
IRIS International, Inc. Pipeline Products by Development Stage 10
IRIS International, Inc. Pipeline Products by Therapy Area 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *